JangDong Seo

Dr. JangDong Seo

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2022 in BioMed Research International
Verified
Journal Article
Open access
PDF file
YLYu-Huei Lin
Yu-Huei Lin
HJHsiu-Ju Jen
Hsiu-Ju Jen
YLYen-Kuang Lin
Yen-Kuang Lin
JSJangDong Seo
JangDong Seo
WCWen-Pei Chang
Wen-Pei Chang
The majority of shift nurses are female, there is still an expectation that they fulfil the traditional role of women in the family in Asia, often conflicting with shift work, increases stress, and affects cortisol secretion patterns. This study was to understand the changes in the cortisol awakening response (CAR) and work stress in nursing personnel working in different shifts. We recruited 41 female shift nurses. We administered the Taiwan Nurse Stress Checklist (NSC), and the nurses themselves collected saliva samples upon waking and 30 minutes after waking for three consecutive days at home. The saliva samples enabled us to analyze the increase in cortisol levels following waking (CARi) of nurses working different shifts (day, evening, and night). We then analyzed the data obtained using a hierarchical linear model (HLM). The results indicated that in terms of stress from the inability to complete personal tasks, the regression coefficients of night‐shift nurses vs. day‐shift nurses (B = 4.39, p < .001) and night‐shift nurses vs. evening‐shift nurses (B = 3.95, p < .001) were positive, which means that night‐shift nurses were under significantly greater stress than day‐shift and evening‐shift nurses. With regard to CARi, the regression coefficients of night‐shift nurses vs. day‐shift nurses (B = −3.41, p < .001) and night‐shift nurses vs. evening‐shift nurses (B = −2.92, p < .01) were negative, which means that night‐shift nurses have significantly lower CARi values than day‐shift and evening‐shift nurses. With regard to cortisol levels 30 minutes after waking, the regression coefficients of night‐shift nurses vs. day‐shift nurses (B = −3.88, p < .01) and night‐shift nurses vs. evening‐shift nurses (B = −3.31, p < .01) were negative, which means that night‐shift nurses have significantly lower cortisol levels 30 minutes after waking than day‐shift and evening‐shift nurses. These results indicate that female night‐shift nurses display the lowest CARi and cortisol levels 30 minutes after waking and are more negatively affected by being unable to complete personal tasks.

20 December 2021 in Thrombosis Journal
Verified
Journal Article
Open access
PDF file
NGNancy Glober
Nancy Glober
LSLauren Stewart
Lauren Stewart
JSJangDong Seo
JangDong Seo
CKChristopher Kabrhel
Christopher Kabrhel
KNKristen Nordenholz
Kristen Nordenholz
JKJeffrey Kline
Jeffrey Kline
Studies have reported COVID-19 as an independent risk factor for arterial thromboemboli. From a cross-sectional sample, we determined the incidence and location of arterial thromboemboli (myocardial infarction, ischemic stroke, peripheral artery), stratified by COVID-19 status, in the RECOVER database, which included data on patients at 45 United States medical centers in 22 states. Epidemiological factors, clinical characteristics and outcomes were collected through a combination of individual chart review and automatic electronic query and recorded in REDCap®. We investigated the association of baseline comorbidities on the development of arterial thromboemboli and analyzed results based on the presence or absence of concomitant COVID-19 infection, testing this association with Chi-squared. We also described use of anticoagulants and statins. Data were collected on 26,974 patients, of which 13,803 (51.17%) tested positive for COVID-19. Incidence of arterial thromboemboli during hospitalization was 0.13% in patients who tested positive for COVID-19 and 0.19% in patients who tested negative. Arterial thromboemboli tended to be more common in extremities than in core organs (heart, kidney, lung, liver) in patients with COVID-19, odds ratio 2.04 (95% CI 0.707 – 5.85). Patients with COVID-19 were less likely to develop an arterial thrombus when on baseline statin medication (p=0.014). Presence of metabolic syndrome predicted presence of core arterial thrombus (p=0.001) and extremity arterial thrombus (p=0.010) in those with COVID-19. Arterial thromboemboli were less common in patients with COVID-19 than in those who tested negative for COVID-19. Presence of a composite metabolic syndrome profile may be associated with arterial clot formation in patients with COVID-19 infection.

24 September 2024 in Critical Care Explorations
Verified
Journal Article
Open access
DHDenise C. Hasson
Denise C. Hasson
KGKatja M. Gist
Katja M. Gist
JSJangDong Seo
JangDong Seo
ESErin K. Stenson
Erin K. Stenson
AKAaron Kessel
Aaron Kessel
OCon behalf of the Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK) Collaborative
on behalf of the Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK) Collaborative
OBJECTIVES: Continuous renal replacement therapy (CRRT) and shock are both associated with high morbidity and mortality in the ICU. Adult data suggest renoprotective effects of vasopressin vs. catecholamines (norepinephrine and epinephrine). We aimed to determine whether vasopressin use during CRRT was associated with improved kidney outcomes in children and young adults. DESIGN: Secondary analysis of Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK), a multicenter, retrospective cohort study. SETTING: Neonatal, cardiac, PICUs at 34 centers internationally from January 1, 2015, to December 31, 2021. PATIENTS/SUBJECTS: Patients younger than 25 years receiving CRRT for acute kidney injury and/or fluid overload and requiring vasopressors. Patients receiving vasopressin were compared with patients receiving only norepinephrine/epinephrine. The impact of timing of vasopressin relative to CRRT start was assessed by categorizing patients as: early (on or before day 0), intermediate (days 1–2), and late (days 3–7). INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Of 1016 patients, 665 (65%) required vasopressors in the first week of CRRT. Of 665, 248 (37%) received vasopressin, 473 (71%) experienced Major Adverse Kidney Events at 90 days (MAKE-90) (death, renal replacement therapy dependence, and/or > 125% increase in serum creatinine from baseline 90 days from CRRT initiation), and 195 (29%) liberated from CRRT on the first attempt within 28 days. Receipt of vasopressin was associated with higher odds of MAKE-90 (adjusted odds ratio [aOR], 1.80; 95% CI, 1.20–2.71; p = 0.005) but not liberation success. In the vasopressin group, intermediate/late initiation was associated with higher odds of MAKE-90 (aOR, 2.67; 95% CI, 1.17–6.11; p = 0.02) compared with early initiation. CONCLUSIONS: Nearly two-thirds of children and young adults receiving CRRT required vasopressors, including over one-third who received vasopressin. Receipt of vasopressin was associated with more MAKE-90, although earlier initiation in those who received it appears beneficial. Prospective studies are needed to understand the appropriate timing, dose, and subpopulation for use of vasopressin.

1 December 2024 in Hypertension
Verified
Journal Article
Closed access
SHStephen R. Hooper
Stephen R. Hooper
MLMarc B. Lande
Marc B. Lande
JFJoseph T. Flynn
Joseph T. Flynn
CHCoral Hanevold
Coral Hanevold
KMKevin E. Meyers
Kevin E. Meyers
EUElaine M Urbina
Elaine M Urbina
BACKGROUND: We studied whether increased systolic blood pressure (SBP), as determined by auscultatory SBP, ambulatory SBP, and the number of cardiovascular health risk indicators, are associated with neurocognition in adolescents. METHODS: This cross-sectional study included 365 adolescents (mean age, 15.5 years) from 6 academic medical centers in the United States. The sample was 59.5% male, 52.6% White, with 23.9% of the caregivers having less than or equal to a high school degree. Primary exposures included the following: auscultatory SBP, ambulatory SBP, and the number of cardiovascular risk factors. Neurocognitive outcomes comprised nonverbal IQ, attention, and parent ratings of executive functions. RESULTS: After examining the models for the effects of targeted covariates (eg, maternal education), higher auscultatory SBP was associated with lower nonverbal IQ (β=−1.39; P <0.001) and verbal attention (β=−2.39; P <0.05); higher ambulatory 24 hours. SBP (β=−21.39; P <0.05) and wake SBP (β=−21.62; P <0.05) were related to verbal attention; and all 3 ambulatory blood pressure measures were related to sustained attention accounting for small to medium amounts of variance (adjusted R 2 =0.08–0.09). Higher ambulatory blood pressure sleep SBP also was significantly associated with parent ratings of behavior regulation (β=12.61; P <0.05). These associations remained stable after a sensitivity analysis removed cases with hypertension. Number of cardiovascular risk factors performed similarly, with more risk factors being associated with lower nonverbal IQ (β=−1.35; P <0.01), verbal attention (β=−1.23; P <0.01), and all parent ratings of executive functions. CONCLUSIONS: Elevated SBP, even below the hypertension range, and general cardiovascular health are associated with neurocognitive outcomes in adolescents. How these findings might guide clinical care is worthy of additional study.

1 May 2025 in Academic Pediatrics
Verified
Journal Article
Closed access
CSChristiana J. Stark
Christiana J. Stark
JZJeffrey Zhang
Jeffrey Zhang
JWJessica Walters
Jessica Walters
DDDominick DeBlasio
Dominick DeBlasio
JSJangDong Seo
JangDong Seo
MKMelissa Klein
Melissa Klein

3 October 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
Robert SiegelRobert Siegel
Robert Siegel
CKChristopher Kist
Christopher Kist
SKShelley Kirk
Shelley Kirk
RKRoohi Kharofa
Roohi Kharofa
KSKristin M. W. Stackpole
Kristin M. W. Stackpole
NKNadine Kasparian
Nadine Kasparian
Background/Objectives: Adherence to pediatric obesity treatment can be challenging. Monetary incentives improve adherence to lifestyle interventions, with incentives framed as loss often more effective than those framed as gain. The objectives of this study were to determine if monetary incentives in the form of gift cards would improve adherence to an obesity treatment intervention and whether framing the incentive as either loss or gain affected adherence. Methods: Sixty adolescents with obesity (body mass index of ≥95th percentile for age and sex) were recruited from our pediatric obesity treatment program. They were randomized into one of three groups and given a monthly adherence score (AS) of up to 100 points. These points were based on completing a medical visit, reporting on diet intake, and measuring daily steps on a wearable tracker. The Gain Group (GG), N = 20, started each month with USD 0 in a virtual account and increased their monetary reward up to USD 100 depending on AS. The Loss Group (LG), N = 21, began each month with USD 100 in their virtual account, which decreased based on adherence. The Control Group (CG), N = 19, received USD 10 monthly. Results: Adherence was highest in the GG, with 66.0 points, compared to the LG, with 54.9 points, and CG, with 40.6 points, with p < 0.01. The GG had greater adherence to their step goal (14.6) and dietary reporting (18.7) compared to the LG (10.0 and 13.9) and the CG (3.9 and 8.1), p < 0.005. Conclusions: Gain-framed incentives are superior to loss-framed ones in improving adherence to pediatric obesity treatments.